Metrics
1 Record Views
- Title
- POSTER: AML-629 A Phase 2 Study of Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia: Outcomes by Number of Prior Treatment Regimens
- Creators
- Eunice S.Wang - Roswell Park Comprehensive Cancer CenterJorge E. Cortes - Division of Hematology and SCT, Georgia Cancer Center, Augusta, GA, USAAndrew H.Wei - Walter and Eliza Hall Institute of Medical ResearchStéphane de Botton - Institut Gustave RoussyAntonio Curti - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology Seragnoli, Bologna, ItalyPau Montesinos - Hospital Universitari i Politècnic La FeKaren W.L. Yee - Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, CanadaJoseph G. Jurcic - Columbia University Irving Medical CenterWilliam B. Donnellan - Sarah Cannon Research InstituteJay Yang - Wayne State UniversityBrian A. Jonas - University of California, DavisAaron D. Sheppard - RigelHua Tian - RigelJustin M. Watts - University of Miami
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.25, pp.S191-S192
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032796985502976